About Pharmasaga

Pharmasaga is a spin-off of Academia Sinica and was founded in Jan 2021. Our core technology is a drug discovery platform composed of molecular docking, chemistry and biology for drug discovery, developed by Dr Wen-Chin Yang, Academia Sinica. With this platform, we developed first-in-class Pdia4 inhibitors for diabetes. The Pdia4 inhibitors can be used as a brand-new beta cell-centric approach to reducing beta cell failure and, in turn, diabetes. More importantly, the Pdia4 inhibitors can reverse diabetes alone and in combination with metformin.